DarioHealth Corp. priced its previously announced public offering at $3.10 per share to raise $4.5 million in gross proceeds.

The company will issue 1,450,000 shares to raise funds for product commercialization and other general working capital purposes. DarioHealth has also granted underwriters a 45-day option to purchase up to an additional 217,500 of the shares offered.

The offering is expected to close April 5, with Aegis Capital Corp. is acting as the sole book-running manager.